CompaniesByCap
LEXX
Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare

Lexaria Bioscience Corp. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Aug 2025Aug 2024Aug 2023Aug 2022Aug 2021Aug 2020Aug 2019Aug 2018Aug 2017Aug 2016
Revenues
Revenue705,923464,278226,208255,397722,738384,543222,610433,28763,63940,718
Gross Profit703,203459,456194,708183,556547,392215,415199,717408,10233,889-4,897
Profitability
Operating Income-11.9M-5.8M-6.5M-6.6M-5.7M-1.3M
EBITDA-11.8M-5.7M-6.4M-6.5M-5.6M
Net Income-11.9M-5.8M-6.7M-7.3M-4.0M-4.1M-4.2M-6.6M-1.9M-1.3M
Per Share Data
EPS (diluted)$-0.66$-0.47$-1.01
Shares Outstanding (dil.)18M12M7M6M6M3M79M76M68M51M

Lexaria Bioscience Corp. Income Statement — FAQ

Lexaria Bioscience Corp. (LEXX) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LEXX's income statement history?

The chart and table above show Lexaria Bioscience Corp.'s income statement by year and by quarter, including the growth rate.